Fluidra
€17.50Change from previous close: +1.80%Absolute change: +€0.31
At a glance
- Revenue growth
- +3.96%
- 2025 vs 2024
- Net income growth
- +27.49%
- 2025 vs 2024
- Net margin
- 7.9%
- 2024: 6.5%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total revenue | 718 | 572 | 468 | 674 | 571 |
| Cost of revenue | 299 | 235 | 183 | 286 | 235 |
| Gross profit | 419 | 337 | 285 | 388 | 337 |
| Operating income | 153 | 78.5 | 35.1 | 140 | 83.1 |
| EBIT | 154 | 83.2 | 24.1 | 161 | 86.4 |
| EBITDA | 194 | 122 | 67.2 | 200 | 127 |
| Interest expense | 43.0 | 21.1 | 6.7 | 40.0 | 21.4 |
| Pre-tax income | 111 | 62.1 | 17.4 | 121 | 65.0 |
| Income tax | 29.3 | 16.3 | 4.5 | 32.0 | 17.1 |
| Net income | 80.4 | 45.5 | 12.6 | 87.8 | 47.7 |
| Net income to common shareholders | 80.4 | 45.5 | 12.6 | 87.8 | 47.7 |
| Basic EPS | — | 0.24 | — | — | 0.25 |
| Diluted EPS | — | 0.24 | — | — | 0.25 |
| Average shares (basic) | — | 190 | — | — | 191 |
| Average shares (diluted) | — | 190 | — | — | 191 |